Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Lifson

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Nature|January 12, 1995
Viral dynamics in human immunodeficiency virus type 1 infectionX Wei, S K Ghosh, M E Taylor, et al.
AIDS (London, England)|December 1, 1990
The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex: a phase I studyJ O Kahn, L D Kaplan, J G Gambertoglio, et al.
Journal of Virology|August 10, 2000
Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virusC G Murphy, W T Lucas, R E Means, et al.
Journal of Virology|October 24, 2000
Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virionsS W Wang, P A Kozlowski, G Schmelz, et al.
Nature Medicine|December 10, 1998
Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplificationV M Hirsch, M E Sharkey, C R Brown, et al.
AIDS Research and Human Retroviruses|June 27, 1998
Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaquesK K Van Rompay, M L Marthas, J D Lifson, et al.
Virology|November 18, 2000
Lasting effects of transient postinoculation tenofovir [9-R-(2-Phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaquesM S Smith, L Foresman, G J Lopez, et al.
Journal of Virology|October 6, 1997
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infectionM A Nowak, A L Lloyd, G M Vasquez, et al.
Journal of Virology|May 11, 1999
Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuationR P Johnson, J D Lifson, S C Czajak, et al.
Journal of Medical Primatology|October 23, 2002
Whole inactivated SIV virion vaccines with functional envelope glycoproteins: safety, immunogenicity, and activity against intrarectal challengeJ D Lifson, M Piatak, J L Rossio, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Nature|January 12, 1995
Viral dynamics in human immunodeficiency virus type 1 infectionX Wei, S K Ghosh, M E Taylor, et al.
AIDS (London, England)|December 1, 1990
The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex: a phase I studyJ O Kahn, L D Kaplan, J G Gambertoglio, et al.
Journal of Virology|August 10, 2000
Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virusC G Murphy, W T Lucas, R E Means, et al.
Journal of Virology|October 24, 2000
Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virionsS W Wang, P A Kozlowski, G Schmelz, et al.
Nature Medicine|December 10, 1998
Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplificationV M Hirsch, M E Sharkey, C R Brown, et al.
AIDS Research and Human Retroviruses|June 27, 1998
Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaquesK K Van Rompay, M L Marthas, J D Lifson, et al.
Virology|November 18, 2000
Lasting effects of transient postinoculation tenofovir [9-R-(2-Phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaquesM S Smith, L Foresman, G J Lopez, et al.
Journal of Virology|October 6, 1997
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infectionM A Nowak, A L Lloyd, G M Vasquez, et al.
Journal of Virology|May 11, 1999
Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuationR P Johnson, J D Lifson, S C Czajak, et al.
Journal of Medical Primatology|October 23, 2002
Whole inactivated SIV virion vaccines with functional envelope glycoproteins: safety, immunogenicity, and activity against intrarectal challengeJ D Lifson, M Piatak, J L Rossio, et al.
Pageof 9